___

1. Cate, R.L., Mattaliano, RJ., Hession, C., Tizard, R., Farber, N M.,Cheung, A ,et al. I solation of the bovine and human gene s for Müllerian inhibiting substance and expressian of the human gene in animal ce lls. Cell 1986;45:685-98.

2. Rey, R., Lukas-Croisier, C., Lasa/a, C. & Bedecarras, P. AMH/ MIS: what we know already about the gene, the protein and its regu/ation. Molecular andCellu/ar Endocrinology 2003;15:21- 31.

3. Tei.xeira, J., Maheswaran, S. & Donahoe, P.K. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. E ndaerine Review s 2001;22:657-74.

4. Knebelmann, B., Boussin, L., Guerrier, D., Legeai, L., Kahn, A., Josso,N.,et al Anti-Müllerian hormoneBruxelles: a nonsense mutation associated w ith the persistent Müllerian duct syndrome. Proceedings of the National Academy of Sciences of the UnitedStates of America 1991;88: 3767-71.

5. Behringer, R.R., Finegold, MJ. & Cate, R.L. Müllerian inhibiting substance janetion during mammalian sexual development. Cell 1994; 79 :415-25.

6. Rajpert-De Meyts, E., Jorgensen, N., Graem, N., Müller, J., Cate, R.L., Skakkebaek, NE. Expressian of anti-Müllerian hormone during normal and pathological gonadal development: association with dijferentiation of Sertali and granulosa ce lls. Journal of Clinical Endocrinology and Metabolism, 1999; 84:3836-44.

7. Baarends, W.M., Uilenbroek, J.T., Kramer, P., Hoogerbrugge, J.W., vanLeeuwen, E.C., Themmen, A.P., e al. Anti-Müllerian hormone and anti-Müllerian hormone type II receptar messenger ribonucleic acid expressian in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology, 1995;136:4951-62.

8. Salmon, NA., Handyside, A.H., Joyce, !.M. Oocyte regu/ation of anti- Müllerian hormone expressian in granulosa ce lls during ovarian follicle development in mi ce. Developmental Biology 2004;266:201-8.

9. Josso, N., di Clemente, N., Gouedard, L. Anti-Müllerian hormone and it s receptors. Malecular and C ellalar Endocrinology 2001;179:25-32.

10. Imbeaud, S., Carre-Eusebe, D., Rey, R., Belville, C., Josso, N., Picard, J.Y. Malecular genetics of the persistent müllerian duct syndrome: a study of 19 families. Human Malecular Genetic s 1994;3:125-31.

ll. Ingraham, HA., Hirokawa, Y., Roberts, L.M., Mellon, S.H., McGee, E., Nachtigal, M.W.et al. Auloerine and paraerine Müllerian inhibiting substance hormone signaling in reproduction. Recent Progress in Hormone Research 2000;55:53- 67.

12. Durlinger, AL., Gruijters, M.J., Kramer, P., Karels, B., Ingraham, HA.,Nachtigal, M.W.,et al . Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-84.

13. Durlinger, A.L., Gruijters, M.J., Kramer, P., Karels, B., Kumar, T.R.,Matzuk, M.M., et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001;142:4891-99.ial follicle growth in the mouse ovary. Endocrinology 2002;143:1076-84.

14. di Clemente, N., Goxe, B., Remy, J.J., Cate, R.L., Josso, N., Vigier, B., et alJnhibitory effect of AMH apon aramatuse activity and LH receptors of granulosa cells of rat and porcine immature ovaries. Endocrine 1994;2:553-8.

15. Tsajriri, A., Picard, J.Y., Josso, N. Immunopurijied anti-Müllerian hormone does not inhibit spontaneous resumption of meiosis in vi tr o of rat oocytes. Biological Reproduction 1988;38:481-5. CiLT: 44 YIL : 2013 SAY!: 1

16. Kim, J.H., Seibel, MM., MacLaughlin, D.T., Donahoe, P.K., Ransil, B.J., Hametz, PA., et al.The inhibitory effects of Müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal ce lls. Journal of Clinical Endocrinology and Metabolism 1992;75:911-7.

17. Seijer, D .B., MacLaughlin, D.T., Penzias, A.S., Behrman, H.R., Asmundson, L., Donahoe, P .K., et al. Gonudotropin-releasing hormone agonist-induced differences in,granulosa eel! cycle kinetics are associated with alterations in follicu/ar fiuid müllerian-inhibiting substance and androgen content. Journal of Clinical Endocrinology and Metabolism 1993;76:711-4.

18. Lee, MM., Donahoe, P .K., Hasegawa, T., Silverman, B., Crist, G.B.,Best, S., et al. Müllerian inhibiting substance in humans: normal levelsjrom infoney to adulthood. Journal of Clinical Endocrinology and Metabolism 1996;81 :571-6.

19. Cook, CL., Siow, Y., Taylor, S., Fal/at, ME. Serum müllerian inhibiting substance levels during normal menstrual cycles. Fertility and Sterility 2000;73 :859-61.

20. La Marea, A., Malmusi, S., Giulini, S., Tamara, L.F., Orvieto, R., Levratti, P., et alAnli-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovu/ation. Human Reproduction 2004;19:2738-41.

21. Long, W.Q., Ranchin, V., Pautier, P., Belville, C., Denizot, P., Cailla, H., et al. Detection of minimal leve/s of serum anti-Müllerian hormone during fallaw-up of patients with ovarian granulosa eel! tumor by means of a highly sensitive enzyme-linked immunosorbeni ass ay. Journal of Clinical Endocrinology and Metabolism 2000;85:540-44

22. La Marea, A., De Le o, V., Giulini, S., Orvieto, R., Malmusi, S., Giannella, L., et al. Anti-Müllerian hormone in premenopausal women and after spontaneous or surgically induced menopause. Journal of the Society for Gynecologic Investigation 2005;12:545-8.

23. de Vet, A., Loven, J.S., de Jang, F.H., Themmen, A.P ., Fauser, B.C. Anti- Müllerian hormone serum !eve ls: a putative marker for ovarian aging. Fertility and Sterility 2002;77: 357-62.

24. Van Rooij, lA., Tonkelaar, I., Broekmans, F .J., Looman, C.W.,Schefferde, G.J., Jang, F .H .. Anti-Müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004;11 :601-6.

25. Fanchin, R., Schonauer, L.M., Righini, C., Frydman, N., Frydman, R., Taieb, ]. Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimu/ation. Human Reproduction 2003 ;18:328-32

26. Fanchin R., Schonauer, L.M., Righini, C Guibourdenche, ]., Frydman,R., Taieb, ]. Serum anti-Müllerian hormone is more strongly re/ated to ovarian follicu/ar status than serum inhibin B, estradiol, FSH and LH on day 3. Human Reproduction 2003;18:323-7.

27. Richardson, S.J. & Nelson, J F. Follicular depfetian during the menopausal transition. Annals of the New York Academy of Sciences 1990 ;592 ,13-20.

28. La Marea, A., Giulini, S., Orvieto, R., De Leo, V., Volpe, A. Anti-Müllerian hormone concentrations in maternal serum during pregnancy. Human Reproduction 2005;20 ,1569-72.

29. Fal/at, M.E., Siow, Y., Marra, M., Cook, C., Carrillo, A. Müllerian-inhibiting substance in follicu/ar fiuid and serum: a comparison of patients with tuhaf factor infertility, polycystic ovary syndrome, and endometriosis. F ertility and Sterility 1997;67:962-5.

30. Mulders, A.G., Laven, J.S., Eijkemansde, M.J., Jang, F.H., Themmen,AP., Fauser, B.C. Changes in anti-Müllerian hormone serum concentrations over time suggest de/ayed ovarian ageing in normogonadotrophic anovu/atory infertility. Human Reprod 2004;19:2036-42

31. Cook, C.L., Siow, Y., Brenner, A.G., Fal/at, M .E. Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertility and Sterility 2002;77:141-6.

32.Pigny, P., Jonard, S., Robert, Y. & Dewailly, D. Serum anti-Müllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006; 91: 941-5

33. La Marea, A., Orvieto, R., Giulini, S., ]asonni, V M., Volpe, A., De Leo, V. Müllerian-inhibiting substance in women with polycystic ovary syndrome: re/ationship with hormonal and metabolic characteristics. Fertility and Sterility 2004;82:970-2.

34. Rey, RA., Belville, C., Nihoul-Fekete, C., Michel-Calemard, L., Forest, M.G., Lahlou, N., et al.Evaluation of gonadalfunction in 107 intersex patients by means of serum antimüllerian hormone measurement. Journal of Clinical Endocrinology and Metabolism 1999;84:627-31.

35. Lane, AH., Lee, M.M., Fuller, A.F. Jr, Kehas, DJ., Donahoe, P.K., MacLaughlin, D.T. Diagnostic utility of Müllerian inhibiting substance de termination in patients with primary and recurrent granulosa eel! tumors. Gynecolo gic Oneology 1999;73:51-5.